RKLB
Rocket Lab USA, Inc.
RKLB has the edge over RRX overall, supported by stronger valuation and stronger modeled upside.
RRX
Regal Rexnord Corporation
RRX has lower modeled downside risk, despite its lower overall score.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
RRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Under pressure |
RRX's revenue, profitability and cash flow are currently stable, but its balance sheet is under pressure.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
RRX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $181 | — |
| Cheap | 21x | $72.73 | -60% |
| Fair | 28x | $96.42 | -47% |
| Expensive | 42x | $145 | -19% |
| Current | 52x | $181 | — |
Historical ranges are pointers, not guarantees.
RRX's PE is in its expensive range at 52x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
RRX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for RRX, with profitability improving. However, they disagree widely on these estimates.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
RRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.07 | +249% |
| Q3 2026 | $3.46 | -10% |
| Q2 2026 | $4.85 | +29% |
| Q1 2026 | $4.30 | +23% |
| Q4 2025 | $4.20 | +43% |
| Q3 2025 | $3.86 | +22% |
| Q2 2025 | $3.75 | +$3.77 |
| Q1 2025 | $3.50 | +$3.98 |
| Q4 2024 | $2.94 | +$3.81 |
RRX has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over RRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
RRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +6.1% |
| Q2 2026 | $1.6B | +4.2% |
| Q1 2026 | $1.5B | +4.3% |
| Q4 2025 | $1.5B | +4.3% |
| Q3 2025 | $1.5B | +1.3% |
| Q2 2025 | $1.5B | -3.3% |
| Q1 2025 | $1.4B | -8.4% |
| Q4 2024 | $1.5B | -9.1% |
RRX's revenue has grown year over year for five quarters in a row: $1.6B last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | -6.5 points |
| Q2 2026 | 14% | +1.6 points |
| Q1 2026 | 10% | -0.9 points |
| Q4 2025 | 11% | +2 points |
| Q3 2025 | 12% | -0.1 points |
| Q2 2025 | 12% | -0.3 points |
| Q1 2025 | 11% | +2.6 points |
| Q4 2024 | 8.8% | -2.2 points |
RRX has the edge over RKLB on profitability, with a higher operating margin.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
RRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $193.7M | +11% |
| Q2 2026 | $154.2M | -69% |
| Q1 2026 | -$2.5M | -103% |
| Q4 2025 | $140.6M | -24% |
| Q3 2025 | $174M | +39% |
| Q2 2025 | $493M | +292% |
| Q1 2025 | $85.5M | +32% |
| Q4 2024 | $183.9M | +7.6% |
RRX has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
RRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -300K shares |
| 1 year | 0% | -- |
| 3 years | +0.5% | +300K shares |
| 5 years | +62% | +25.6M shares |
| Available history | +62% | +25.5M shares |
RRX has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $55.2M |
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 3.6x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.4x | High |
RRX's net debt is about 3.6 years of its operating earnings (EBITDA), down from 3.8 years a year ago.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
RRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.7 | Neutral |
| Stochastic | 43.2 | Neutral |
RRX's weekly RSI is 53 (neutral) and its Stochastic is 43 (neutral).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
RRX PE vs Industrials Sector
| Metric | RRX | Sector median | Relative |
|---|---|---|---|
| PE | 52x | 24x | 117% above |
| PE % | 97 | 58 | 39 pts above |
RRX is trading at 52x earnings, a 117% premium to the Industrials sector's median of 24x.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
RRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $161.2 | 12% above |
| 20 week MA | $174.9 | 3.2% above |
| 50 week MA | $183.1 | 1.4% below |
| 100 week MA | $160.9 | 12% above |
| 200 week MA | $155.4 | 16% above |
RRX has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.
RRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $85.4 | $120.2 | +41% |
| 2021 | $120.2 | $165.2 | +37% |
| 2022 | $165.2 | $118.6 | -28% |
| 2023 | $118.6 | $148.0 | +25% |
| 2024 | $148.0 | $156.5 | +5.7% |
| 2025 | $156.5 | $145.2 | -7.2% |
| 2026 YTD | $145.2 | $180.5 | +24% |
RRX has the edge over RKLB on returns for 2026, with the stronger performance.